» Authors » Avraham Eisbruch

Avraham Eisbruch

Explore the profile of Avraham Eisbruch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 247
Citations 7710
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rao K, Sreeram M, de Bree R, Mendenhall W, Strojan P, Stenman G, et al.
Cancers (Basel) . 2025 Mar; 17(5). PMID: 40075709
To evaluate the impact of postoperative radiotherapy (PORT) on oncological outcomes in node-negative early-stage oral squamous cell carcinoma (OSCC) with perineural invasion (PNI). : A systematic review and meta-analysis was...
2.
Benjamin W, Feng A, Heft Neal M, Bellile E, Casper K, Malloy K, et al.
Oral Oncol . 2024 Jun; 156:106917. PMID: 38945011
Background: Neoadjuvant chemotherapy for induction selection of definitive treatment (IS) protocols have shown excellent outcomes for organ preservation and survival in patients with T3 laryngeal squamous cell carcinoma (LSCC). We...
3.
Strojan P, Kokalj M, Plavc G, Ng S, Nuyts S, Chiesa-Estomba C, et al.
Cancers (Basel) . 2024 Jun; 16(11). PMID: 38893215
Stereotactic body radiotherapy (SBRT) is characterized by a high dose per fraction, well-defined small targets, superior dose conformity, and a steep off-target dose gradient. A literature search was conducted to...
4.
Tham J, Ng S, Khor R, Wada M, Gan H, Thai A, et al.
J Clin Med . 2024 Jun; 13(11). PMID: 38892731
The treatment of head and neck cancers (HNCs) encompasses a complex paradigm involving a combination of surgery, radiotherapy, and systemic treatment. Locoregional recurrence is a common cause of treatment failure,...
5.
Dong J, Ng W, Wong C, Li J, Bollen H, Chow J, et al.
Radiother Oncol . 2024 Mar; 195():110258. PMID: 38537680
This systematic review examines the role of dosimetric parameters in predicting temporal lobe necrosis (TLN) risk in nasopharyngeal carcinoma (NPC) patients treated with three-dimensional conformal RT (3D-CRT), intensity-modulated radiation therapy...
6.
Swiecicki P, Bellile E, Dragovic A, McHugh J, Udager A, Mierzwa M, et al.
Clin Cancer Res . 2024 Mar; 30(11):2393-2401. PMID: 38517480
Purpose: Locoregionally advanced HPV+ oropharyngeal squamous cell carcinoma (OPSCC) has excellent cure rates, although current treatment regimens are accompanied by acute and long-term toxicities. We designed a phase II deescalation...
7.
Chow J, Ho J, Man Cheung K, Johnson D, Ip B, Beitler J, et al.
Radiother Oncol . 2024 Mar; 194:110200. PMID: 38438018
Radiotherapy is one of the mainstay treatment modalities for the management of non-metastatic head and neck cancer (HNC). Notable improvements in treatment outcomes have been observed in the recent decades....
8.
Lopez F, Agaimy A, Franchi A, Suarez C, Vander Poorten V, Makitie A, et al.
Virchows Arch . 2024 Feb; 484(4):567-585. PMID: 38386106
Olfactory neuroblastomas are uncommon malignancies that arise from olfactory receptor cells located high in the nasal cavity. Accurate diagnosis plays a crucial role in determining clinical results and guiding treatment...
9.
Eisbruch A
Int J Radiat Oncol Biol Phys . 2023 Dec; 118(1):154-156. PMID: 38049221
No abstract available.
10.
Rao K, Arora R, Dange P, Nagarkar N, Makitie A, Kowalski L, et al.
Oncol Ther . 2023 Oct; 11(4):461-480. PMID: 37804420
Objective: To determine the overall surgical outcomes of infranotch T4b oral cancers and compare them with T4a oral cancers. Methods: PubMed, EMBASE and Cochrane databases from 2000 to 2022 were...